Clinica Gema Leon
8
0
0
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 8 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (8)
Radiofrequency in Patients Post Covid 19 With Respiratory Sequelae.
Role: lead
Efficacy of Non-invasive Neuromodulation Treatments for COVID-19 Sequelae
Role: lead
Radiofrequency Intervention in Post-COVID-19 Patients With Musculoskeletal Sequelae
Role: lead
Radiofrequency Intervention in Neurological Pathologies Post COVID-19
Role: lead
Craniosacral Therapy Improves Infant Neurodevelopment
Role: lead
Efficacy of the Most Commonly Used Physiotherapeutic Treatments for Acute Lower Limb Fatigue in Athletes
Role: lead
Craniosacral Test and Primitive Reflexes in Infant Neurodevelopment
Role: lead
Craniosacral Therapy Children's, Balance-Coordination
Role: lead
All 8 trials loaded